Aidapak Recalls Acyclovir Capsules Due to Potential Labeling Mixup
Aidapak Services, LLC is recalling 493 Acyclovir 200 mg capsules because they may have been mislabeled as other prescription drugs.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling mixup that could lead to the administration of incorrect prescription medications, posing a risk of harm without reported fatalities or hospitalizations.
Plain-English summary
Aidapak Services, LLC is recalling 493 Acyclovir 200 mg capsules (NDC 00093894001) due to a potential labeling mixup. The recalled capsules may have been mislabeled as Cyanocobalamin 1000 mcg tablets, Metoprolol Tartrate 25 mg tablets, Metoprolol Tartrate 50 mg tablets, or Acetazolamide.
The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The recall involves specific pedigree codes and expiration dates, including AD60272_4 (EXP: 5/22/2014), W002899 (EXP: 6/10/2014), W003911 (EXP: 6/27/2014), and W003483 (EXP: 6/20/2014).
Consumers and healthcare providers should check their inventory for these specific products and stop using them if they match the recalled codes. The FDA has classified this as a Class II recall, indicating that use of the product could cause temporary or medically reversible health consequences.
The recalled product
- Product
- ACYCLOVIR, Capsule, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093894001.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 493
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- ACYCLOVIR
- Capsule
- 200 mg has the following codes: Pedigree: AD60272_4
- EXP: 5/22/2014
- Pedigree: W002899
- EXP: 6/10/2014
- Pedigree: W003911
- EXP: 6/27/2014
- Pedigree: W003483
- EXP: 6/20/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Cyproheptadine HCL Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Citalopram Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Metoprolol Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- SevereFDA Recalls Misoprostol Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Metoprolol Tartrate Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Phosphorus Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22